Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Combined treatment of intravitreal bevacizumab and intravitreal triamcinolone in patients with retinal vein occlusion.

× No keyword cloud information.

3 in total

1. Intravitreal bevacizumab (Avastin) for macular oedema secondary to retinal vein occlusion: 12-month results of a prospective clinical trial.

Authors: F Prager; S Michels; K Kriechbaum; M Georgopoulos; M Funk; W Geitzenauer; K Polak; U Schmidt-Erfurth
Journal: Br J Ophthalmol Date: 2008-12-15 Impact factor: 4.638

2. Combined treatment of intravitreal bevacizumab and intravitreal triamcinolone in patients with retinal vein occlusion: 6 months of follow-up.

Authors: Rita Ehrlich; Thomas A Ciulla; Adam M Moss; Alon Harris
Journal: Graefes Arch Clin Exp Ophthalmol Date: 2009-11-08 Impact factor: 3.117

3. Is there tachyphylaxis to intravitreal anti-vascular endothelial growth factor pharmacotherapy in age-related macular degeneration?

Authors: Shlomit Schaal; Henry J Kaplan; Tongalp H Tezel
Journal: Ophthalmology Date: 2008-10-18 Impact factor: 12.079

3 in total

1. Twelve-month experience with Ozurdex for the treatment of macular edema associated with retinal vein occlusion.

Authors: W J Mayer; A Wolf; M Kernt; D Kook; A Kampik; M Ulbig; C Haritoglou
Journal: Eye (Lond) Date: 2013-04-19 Impact factor: 3.775

2. Grid photocoagulation combined with intravitreal bevacizumab for recurrent macular edema associated with retinal vein occlusion.

Authors: Ken Ogino; Akitaka Tsujikawa; Tomoaki Murakami; Yuki Muraoka; Yumiko Kurashige; Nagahisa Yoshimura
Journal: Clin Ophthalmol Date: 2011-07-26

Review 3. Changing paradigms of anti-VEGF in the Indian scenario.

Authors: P Mahesh Shanmugam
Journal: Indian J Ophthalmol Date: 2014-01 Impact factor: 1.848

3 in total